I uncover a high-quality dividend growth stock that appears to be undervalued each week for Daily Trade Alert, which is a site that focuses on dividend growth investing, stocks, and unique investment opportunities. I’ve been writing for them for years now, and they’re just great over there. Each week, I publish an excerpt of my work, when it’s fresh off the press. That way, you readers are given the opportunity to check it out. The content is totally free. I hope you enjoy!
You could work hard for money.
Or you could let money work hard for you.
Which way do you think is more effective and enjoyable?
Money is far more effective at working.
It can work 24/7. And it can compound itself.
You can’t say that about yourself.
Image courtesy of: Stuart Miles at FreeDigitalPhotos.net.
Interesting analysis on AMGN. This is one I have never owned or really considered. There recent dividend growth is really impressive bringing the yield to nearly 3%. I need to put it on my watch list and look for good opportunities to initiate a position. Tom
Tom,
It’s a very solid company. Happy to own a slice. 🙂
Cheers!
For a biotech, it doesn’t get more “blue chip” than AMGN. I have a small position in AMGN and GILD but would like to bulk up both holdings over time. No doubt, the biotech space can be quite volatile at times, but with strong pipelines AMGN and other heavyweights can weather surprise FDA rules and regs. Thanks for sharing.
DH,
I’m with you. About as “blue chip” as they get in this space. 🙂
Best regards!